Medi Assist Healthcare Services Ltd Hits All-Time Low Amidst Prolonged Downtrend

Stock Performance Overview

On 4 Mar 2026, Medi Assist Healthcare Services Ltd recorded an intraday low of Rs.345.9, representing a 2.77% drop during the session and closing with a day change of -2.11%. This decline was slightly steeper than the Sensex’s fall of 1.97% on the same day. The stock’s performance has been notably weaker than the broader market and its sector peers, with the miscellaneous sector itself falling by 2.27%.

The stock has been on a consecutive losing streak for nine days, resulting in a cumulative return of -16.33% over this period. When viewed over longer time frames, the underperformance becomes more pronounced. Over the past one month, the stock has declined by 16.05%, compared to the Sensex’s 6.16% fall. The three-month return stands at -26.06%, significantly lagging behind the Sensex’s 7.75% gain. Year-to-date, Medi Assist has fallen 24.24%, while the Sensex has declined by 7.70%.

Over the last year, the stock has generated a negative return of 22.78%, contrasting sharply with the Sensex’s positive 7.77% gain. The three-year and five-year returns for Medi Assist remain at 0.00%, indicating no appreciable capital appreciation, while the Sensex has delivered 31.51% and 54.70% respectively over the same periods. The ten-year return for the stock is also flat, whereas the Sensex has surged by 219.14%.

Technical Indicators and Moving Averages

The stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning underscores the prevailing bearish sentiment and the absence of upward momentum in the near term. The consistent trading below these averages typically signals sustained weakness and a lack of buying interest at higher price levels.

Financial Metrics and Profitability Trends

Medi Assist Healthcare Services Ltd’s recent quarterly results have contributed to the subdued market sentiment. The Profit Before Tax (PBT) excluding other income for the quarter stood at Rs.15.11 crores, reflecting a decline of 23.9% compared to the average of the previous four quarters. The Profit After Tax (PAT) for the quarter was Rs.11.11 crores, down by 45.4% relative to the prior four-quarter average. Additionally, interest expenses reached a quarterly high of Rs.8.39 crores, exerting further pressure on profitability.

Despite these setbacks, the company maintains a Return on Equity (ROE) of 14.05%, which indicates a degree of fundamental strength in its core operations. However, the valuation metrics suggest the stock is trading at a premium, with a Price to Book Value ratio of 4.6. This valuation is considered expensive relative to its historical averages and peer group benchmarks, although the current market price reflects a discount compared to these peers’ historical valuations.

Comparative Sector and Market Context

Within the insurance sector, Medi Assist’s performance has been notably weaker than the broader market indices and sectoral peers. The stock’s negative returns over multiple time horizons contrast with the more resilient performance of the BSE500 and Sensex indices. Over the past three months, the stock’s return of -26.06% is significantly below the Sensex’s 7.75% gain, and its one-year return of -22.78% also trails the BSE500 benchmark.

The stock’s Mojo Score currently stands at 23.0, with a Mojo Grade of Strong Sell as of 2 Dec 2025, an upgrade from the previous Sell rating. The Market Cap Grade is rated at 3, reflecting a mid-tier market capitalisation within its sector. These ratings encapsulate the company’s recent financial performance and market positioning.

Long-Term Performance and Valuation Considerations

Over the long term, Medi Assist Healthcare Services Ltd has not delivered capital appreciation, with zero returns recorded over three, five, and ten-year periods. This contrasts sharply with the Sensex’s robust gains of 31.51%, 54.70%, and 219.14% respectively over the same durations. The absence of long-term price growth highlights the challenges the company has faced in generating shareholder value.

While the company’s ROE of 14.05% indicates a reasonable level of profitability, the stock’s valuation metrics suggest a disconnect between earnings quality and market pricing. The elevated Price to Book Value ratio of 4.6 points to an expensive valuation relative to book equity, which may be a factor in the stock’s recent price weakness as investors reassess valuation levels amid earnings declines.

Summary of Key Financial Indicators

The recent quarterly results reveal a contraction in profitability, with PBT excluding other income down by nearly a quarter and PAT declining by over 45% compared to recent averages. Interest costs have risen to their highest quarterly level, further impacting net earnings. Despite these pressures, the company sustains a moderate ROE, reflecting some underlying operational resilience.

From a market perspective, the stock’s performance has been consistently below sector and benchmark indices across multiple time frames, with a notable nine-day losing streak culminating in the new all-time low price. The technical picture remains weak, with the stock trading below all major moving averages.

Conclusion

Medi Assist Healthcare Services Ltd’s fall to an all-time low of Rs.345.9 on 4 Mar 2026 marks a significant point in its recent market journey. The stock’s sustained decline over the past nine sessions, combined with disappointing quarterly earnings and elevated interest expenses, has contributed to a challenging valuation and market sentiment environment. While the company maintains a reasonable ROE, the lack of capital appreciation over extended periods and the current valuation premium highlight the complexities facing the stock in the current market context.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today